Labriola, C., Garman, K., Epplein, M., Zuzul, R., Alagesan, P., Brown, H. S., … Hyslop, T. (2023). S1870 Antibiotic Use and Predictors of H. pylori Eradication as Part of the Gastric Immune Response and Cancer Interception Translational Project. In American Journal of Gastroenterology (Vol. 118, pp. S1388–S1388). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.14309/01.ajg.0000957120.50286.81

Labriola, Caroline, Katherine Garman, Meira Epplein, Rachel Zuzul, Priya Alagesan, Hannah Sofia Brown, Frances Wang, Grace Sekaya, and Terry Hyslop. “S1870 Antibiotic Use and Predictors of H. pylori Eradication as Part of the Gastric Immune Response and Cancer Interception Translational Project.” In American Journal of Gastroenterology, 118:S1388–S1388. Ovid Technologies (Wolters Kluwer Health), 2023. https://doi.org/10.14309/01.ajg.0000957120.50286.81.

Labriola C, Garman K, Epplein M, Zuzul R, Alagesan P, Brown HS, et al. S1870 Antibiotic Use and Predictors of H. pylori Eradication as Part of the Gastric Immune Response and Cancer Interception Translational Project. In: American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2023. p. S1388–S1388.

Labriola, Caroline, et al. “S1870 Antibiotic Use and Predictors of H. pylori Eradication as Part of the Gastric Immune Response and Cancer Interception Translational Project.” American Journal of Gastroenterology, vol. 118, no. 10S, Ovid Technologies (Wolters Kluwer Health), 2023, pp. S1388–S1388. Crossref, doi:10.14309/01.ajg.0000957120.50286.81.

Labriola C, Garman K, Epplein M, Zuzul R, Alagesan P, Brown HS, Wang F, Sekaya G, Hyslop T. S1870 Antibiotic Use and Predictors of H. pylori Eradication as Part of the Gastric Immune Response and Cancer Interception Translational Project. American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2023. p. S1388–S1388.